Regulatory change
CFPB reverses course: Moves to scrap medical debt reporting ban
Nick Walsh, Consultant · · 2 minute read
US
In a striking policy reversal, the Consumer Financial Protection Bureau (CFPB) has formally asked a federal court to vacate its own rule that would have banned medical debt from appearing on consumer credit reports.
Consultant, arum
What you need to know
- The CFPB asked the court to scrap its own medical debt reporting ban in a joint filing on 30 April 2025.
- Medical debt can return to US credit files, which changes affordability and collections decisions.
- A regulator reversing its own rule is a reminder to build for change, not for a fixed rulebook.
This move, announced in a joint court filing on April 30, 2025, aligns the CFPB with industry groups that had previously sued to block the regulation.
So, what does this mean for the credit industry and consumers in the US? Let's take a look at the details.
What was the medical debt rule?
The rule, finalised in January 2025 during the Biden administration, was designed to:
- Prohibit lenders from considering medical debt when making lending decisions
- Ban credit reporting agencies from including medical debt information on credit reports and scores
- Had it taken effect, the rule was expected to remove up to $49 billion in medical debt from the credit reports of 15 million Americans.
- The regulation was originally set to be implemented in March, but legal challenges delayed its implementation until at least June 15, 2025.
- Why the sudden reversal?
- The CFPB's reversal came as it joined the Cornerstone Credit Union League and the Consumer Data Industry Association (two industry groups that had sued to block the rule) in asking the court to strike it down.
- In their joint motion, the parties argued that the rule " exceeds the bureau's authority and is contrary to law ", specifically citing the Fair Credit Reporting Act, which they say permits reporting of coded medical debt and allows creditors to consider it when making lending decisions.
- A memo from the CFPB's chief legal officer indicated the agency will now deprioritise enforcement in areas like medical debt, shifting focus to cases involving clear consumer damages such as fraud.
- What happens next?
- The court will decide whether to formally vacate the rule based on the agreement between the CFPB and industry groups. If the judge agrees, the regulation will be nullified before it ever takes effect, and medical debt will continue to appear on credit reports and influence lending decisions.
- Consumer advocacy groups are seeking to intervene in the proceedings to defend the rule, but the outcome remains uncertain.
- How will this affect consumers and the industry?
- Consumers: If the rule is vacated, millions of Americans could continue to see medical debt affect their credit scores and access to loans.
- States: Several states, including California, Colorado, Connecticut, and New York, have enacted their own restrictions on medical debt reporting, and more may follow, but the federal landscape is now in flux.
- Credit industry: Credit bureaus and lenders argue that access to all debt information, including medical debt, is necessary for accurate credit assessments, while consumer advocates warn this reversal could harm financially vulnerable Americans.
Summary
The CFPB's request to scrap its own medical debt reporting ban marks a significant shift in federal consumer protection policy. The fate of the rule, and the credit profiles of millions, now rests with the courts, as the debate over the role of medical debt in credit reporting continues.
Discuss your collections and recoveries needs with our experts
arum has a global team of specialists in collections and recoveries that can assist you with your technology, strategy and operational needs and help you to deliver good customer outcomes.
From the same author
More from Nick Walsh.
Regulatory changeBNPL regulation confirmed: what it means for consumers and lenders
The UK government has confirmed that third-party BNPL products will be regulated by the FCA from mid-2026. What it means for consumers and lenders.
Nick Walsh · 26 June 2025
Digital and AI8 value drivers for maximising ROI in collections transformations
Transforming your debt collections system is a substantial investment of time, money, and resources.
Nick Walsh · 17 April 2025
Regulatory changeAchieving compliance with the Consumer Duty: Removing sludge practices
One of the key parts of the FCA's Consumer Duty, and in particular the consumer support outcome, is the eradication of sludge processes.
Nick Walsh · 18 March 2025
Keep reading
More from arum.
Regulatory changeBNPL is now regulated. The real work has begun.
On 15 July 2026, Buy Now Pay Later formally entered the FCA's regulatory perimeter.
Stephen Wright · 20 July 2026
Regulatory changeFCA motor finance redress: five things firms will underestimate
Motor finance redress is not a remediation exercise but a large-scale transformation programme. Five things lenders will underestimate.
arum · 31 March 2026
Regulatory changeBNPL regulations 2026: what lenders must do now
What BNPL lenders need in place for 2027, now the FCA expects firms to prove their arrears frameworks work rather than just exist on paper.
Stephen Wright · 20 March 2026
Talk to arum
